跳至主要内容
临床试验/NCT06010030
NCT06010030进行中(未招募)不适用

A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia

Medical College of Wisconsin1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年10月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
试验地点
1
主要终点
Behavioral outcome

研究概览

简要总结

This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.

详细描述

Aphasia is a disturbance of language, primarily caused by brain injury to the left cerebral hemisphere. Aphasia treatments include speech and language therapy and pharmacologic therapy, but several studies have found that these treatments are not completely effective for patients with aphasia, leaving them with residual deficits that significantly add to the cost of stroke-related care. Additionally, the amount and frequency of speech and language therapy delivered may have a critical effect on recovery. Therefore, there is a need for new treatments or adjuncts to existing treatments, such as brain stimulation interventions, that have the potential to show greater improvements in patients with aphasia. One such new approach for non-invasive brain stimulation is transcranial direct current stimulation (tDCS).

This study will examine the effects of tDCS during speech therapy to further examine which method or methods is best for patient recovery. Patients enrolled in the study will undergo language testing that covers a broad range of language functions. Functional Magnetic Resonance Imaging (fMRI) will be completed before and after speech therapy intervention arms to investigate the neural processes affected by tDCS and speech therapy.

Study design:

Patients will be randomly assigned to one of 2 speech therapy groups as well as randomly assigned to one of 2 stimulation groups (active anodal stimulation or sham). Patients will receive one of two different speech therapy treatment interventions to focus on specific processing deficits. Participants will undergo neuropsychological evaluation and fMRI assessment before receiving targeted anodal-tDCS or sham-tDCS for 10 therapy sessions. Participants will then be re-tested using the behavioral assessment measure and fMRI before crossing over to receive the tDCS intervention again, along with the same speech therapy arm. They will complete a behavioral assessment and fMRI at 3 months post Treatment 2 and a final behavioral assessment at 6 months post Treatment 2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Care provider, participant, and outcome assessor are masked for tDCS status.

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must be 18 or older.
  • Patients may not be older than
  • Patients must have a language deficit from left-sided focal neurologic damage (e.g. stroke, tumor).
  • Patients must be adults and have English-language fluency.
  • Patients must be eligible to undergo MRI.
  • Beyond meeting the inclusion criteria, no preference will be given on the basis of race, ethnicity or gender.

排除标准

  • Advanced neurodegenerative disease (i.e. Stage 3 Alzheimer's disease)
  • Neurologic disease (e.g. idiopathic epilepsy, seizure disorders that are not well managed, Parkinson's disease, ALS),
  • Severe psychopathology (e.g. schizophrenia, bipolar disorder, acute major depressive episode)
  • Suspected or diagnosed uncorrectable hearing or vision difficulties, or developmental disabilities (i.e. intellectual disability or learning disability).
  • Contraindications to MRI such as claustrophobia, implanted electronic devices, MRI-incompatible metal in the body, extreme obesity, pregnancy, inability to lie flat, inability to see or hear stimulus materials.
  • Younger than 18 or older than
  • < 6 months post tumor resection.

研究组 & 干预措施

Speech Therapy

Experimental

Participants will be randomized to receive either phonologic-focused speech therapy or semantic-focused speech therapy

干预措施: Speech Therapy (Behavioral)

HD-tDCS

Experimental

Participants will be randomized to receive either anodal HD-tDCS or sham-tDCS.

干预措施: Targeted Transcranial Direct Current Stimulation (Device)

结局指标

主要结局

Behavioral outcome

时间窗: Upon the completion of therapy cycle (a cycle consists of 10 intervention days) and 10 weeks post completion of therapy

Percent improvement on behavioral outcomes after each therapy cycle will be the primary behavioral outcome measure.

次要结局

  • fMRI(3 time points: pre-assessment, 10 weeks post-therapy cycle A and 10 weeks post-therapy cycle B)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Priyanka Shah-Basak, PhD

Assistant Professor

Medical College of Wisconsin

研究点 (1)

Loading locations...

相似试验

HD-tDCS for Phonological Impairment in Aphasia | 临床试验